BACKGROUND Previous studies have implicated reduced
brain-derived neurotrophic factor (
BDNF) expression and
BDNF-
TrkB receptor signaling as well as microglial activation and
neuroinflammation in poststroke depression (PSD). However, the contributions of microglial
BDNF-TrkB signaling to PSD pathogenesis are unclear. MATERIAL AND METHODS We compared depression-like behaviors as well as neuronal and microglial
BDNF and TrkB expression levels in the amygdala, a critical mood-relating limbic structure, in rat models of
stroke, depression, and PSD. Depression-like behaviors were assessed using the
sucrose preference test, open-field test, and weight measurements, while immunofluorescence double staining was employed to estimate
BDNF and TrkB expression by CD11b-positive amygdala microglia and NeuN-positive amygdala neuron. Another group of PSD model rats were examined following daily intracerebroventricular injection of proBDNF,
tissue plasminogen activator (t-PA), or
normal saline (NS) for 7 days starting 4 weeks after chronic unpredictable mild stress (CUMS). RESULTS The numbers of
BDNF/CD11b- and TrkB/CD11b-immunofluorescence-positive cells were lowest in the PSD group at 4 and 8 weeks after CUMS (P0.05). Injection of t-PA increased
BDNF/CD11b- and TrkB/CD11b-positive cells in the amygdala of PSD rats and normalized behavior compared with NS or proBDNF injection (P<0.05). In contrast, proBDNF injection reduced
BDNF and TrkB expression compared with NS (P<0.05). CONCLUSIONS These results suggest that decreased
BDNF and TrkB expression by amygdala microglia may contribute to PSD pathogenesis and depression-like behaviors.